SCHEMBL17812601

SCHEMBL17812601

CCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.62
PAM P19021 2/20 0.56
TSHR P16473 1/20 0.53
MAPT P10636 1/20 0.53
LMNA P02545 4/20 0.51
DNM1 Q05193 1/20 0.51
ALDH1A1 P00352 1/20 0.51
KDM4E B2RXH2 1/20 0.50
DUSP3 P51452 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
ENPP2 Q13822 3/20 0.47
LPAR6 P43657 1/20 0.47
LPAR1 Q92633 1/20 0.47
LPAR4 Q99677 1/20 0.47
LPAR5 Q9H1C0 1/20 0.47
LPAR2 Q9HBW0 1/20 0.47
LPAR3 Q9UBY5 1/20 0.47
PRKCA P17252 1/20 0.47
PRKCE Q02156 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2548639 1.00 DGKA (0.62) DGKAPAMTSHRMAPTLMNA
SCHEMBL11979367 1.00 DGKA (0.62) DGKAPAMTSHRMAPTLMNA
SCHEMBL3412329 1.00 DGKA (0.62) DGKAPAMTSHRMAPTLMNA
SCHEMBL1627955 1.00 DGKA (0.62) DGKAPAMTSHRMAPTLMNA
SCHEMBL8539661 1.00 DGKA (0.62) DGKAPAMTSHRMAPTLMNA
SCHEMBL15024334 1.00 DGKA (0.62) DGKAPAMTSHRMAPTLMNA
SCHEMBL9761793 1.00 DGKA (0.62) DGKAPAMTSHRMAPTLMNA
SCHEMBL526334 1.00 DGKA (0.62) DGKAPAMTSHRMAPTLMNA
SCHEMBL17812663 1.00 DGKA (0.62) DGKAPAMTSHRMAPTLMNA
SCHEMBL17812475 1.00 DGKA (0.62) DGKAPAMTSHRMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250339360-A1 COSMETIC COMPOSITIONS COMPRISING RETINOIDS AND MOISTURIZERS AND METHODS FOR STABLIZING RETINOIDS ELC MANAGEMENT LLC (US) 2025-11-06 US disclosed
US-12410374-B2 Lubricating oil composition, lubrication method, and transmission IDEMITSU KOSAN CO., LTD. (JP) 2025-09-09 US disclosed
WO-2025105449-A1 OIL-IN-WATER TYPE EMULSION COSMETIC 株式会社コーセー 2025-05-22 WO disclosed
US-12257335-B2 Personal care compositions COLGATE-PALMOLIVE COMPANY (US) 2025-03-25 US disclosed
US-20250051680-A1 LUBRICANT COMPOSITION IDEMITSU KOSAN CO.,LTD. (JP) 2025-02-13 US disclosed
EP-4502120-A1 LUBRICANT COMPOSITION Idemitsu Kosan Co.,Ltd. (JP) 2025-02-05 EP disclosed
US-20240384193-A1 LUBRICATING OIL COMPOSITION, LUBRICATION METHOD, AND TRANSMISSION IDEMITSU KOSAN CO.,LTD. (JP) 2024-11-21 US disclosed
CN-118946652-A Lubricating oil composition 出光兴产株式会社 2024-11-12 CN disclosed
US-12083212-B2 Personal care compositions COLGATE-PALMOLIVE COMPANY (US) 2024-09-10 US disclosed
EP-4414441-A1 LUBRICATING OIL COMPOSITION, LUBRICATION METHOD, AND TRANSMISSION Idemitsu Kosan Co.,Ltd. (JP) 2024-08-14 EP disclosed
US-20230174887-A1 LUBRICATING OIL COMPOSITION IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 US disclosed
WO-2023058440-A1 LUBRICATING OIL COMPOSITION, LUBRICATION METHOD, AND TRANSMISSION 出光興産株式会社 2023-04-13 WO disclosed
EP-4130212-A1 LUBRICATING OIL COMPOSITION Idemitsu Kosan Co.,Ltd. (JP) 2023-02-08 EP disclosed
CN-112088206-B Lubricating oil composition 出光兴产株式会社 2023-01-06 CN disclosed
CN-115279872-A Lubricating oil composition 出光兴产株式会社 2022-11-01 CN disclosed
US-11473030-B2 Lubricant composition IDEMITSU KOSAN CO., LTD. (JP) 2022-10-18 US disclosed
US-11452688-B2 Transdermally absorbable base material containing lipid peptide compound KYUSHU UNIVERSITY (JP) 2022-09-27 US disclosed
WO-2022163571-A1 WATER-IN-OIL-TYPE EYELASH COSMETIC 株式会社コーセー 2022-08-04 WO disclosed
US-20220023189-A1 Personal Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-01-27 US disclosed
US-9365715-B2 Thermoplastic elastomer composition and method for the production thereof STYROLUTION EUROPE GMBH (DE) 2016-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11452688-B2 Transdermally absorbable base material containing lipid peptide compound NGLY1, NR1H4, HRH1 DGKA 816/4885PAM 490/4885TSHR 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.